Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
4.91M
-
Shares change
-
+4.91M
-
Total reported value, excl. options
-
$57M
-
Value change
-
+$56.9M
-
Put/Call ratio
-
0.57
-
Number of buys
-
30
-
Price
-
$11.61
Significant Holders of Humacyte, Inc. - COM (HUMA) as of Q3 2021
43 filings reported holding HUMA - Humacyte, Inc. - COM as of Q3 2021.
Humacyte, Inc. - COM (HUMA) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.91M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1.5M shares), Diameter Capital Partners LP (954K shares), Monashee Investment Management LLC (750K shares), CVI Holdings, LLC (500K shares), Maven Securities LTD (500K shares), VANGUARD GROUP INC (290K shares), LPL Financial LLC (115K shares), MORGAN STANLEY (72.3K shares), GEODE CAPITAL MANAGEMENT, LLC (30.9K shares), and Eudaimonia Partners, LLC (25K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.